undefined icon

ABVX - Keuangan

Pre-MarketPre-Market

Abivax SA

$--
0
--
0
Belum ada data.
iconPerforma Harga
Harga kembali 1 minggu-
Harga kembali 1 Bulan-
Harga kembali 3 Bulan-
Harga kembali 6 Bulan-
Harga Tertinggi (52 Minggu)-
Harga Terendah (52 Minggu)-
Latar Belakang Perusahaan
Abivax SA is a clinical-stage biotechnology company developing treatments for chronic inflammatory diseases, including inflammatory bowel disease.

Income Statement

20252024202320222021

Total Revenue

-10.79M4.62M4.58M37,000

Gross Profit

(1.03M)10.79M4.57M(50.76M)(45.52M)

Operating Income

(246.06M)(172.98M)(127.38M)(64.84M)(41.40M)

Net Income

(336.10M)(176.24M)(147.74M)(60.74M)(42.45M)

Net Margin %

--1633.08%-3197.14%-1325.33%-114735.14%

Saham Terkait